Grove Bank & Trust’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
RT
PAS
MSV
AMBIA
BRCM
FFA
BFA
TFA
CI
HAG
Grove Bank & Trust's ELV Position: Q3 2026 in Review
Grove Bank & Trust increased its Elevance Health (ELV) stake by 6.7% in Q3 2026, buying an estimated $82.6K and bringing the position to 3,275 shares worth $1.27M. The position accounts for 0.13% of the portfolio, ranked #103.
Grove Bank & Trust first reported a position in ELV in Q4 2015 and has held it in 28 quarters since. 64 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- Grove Bank & Trust held 3,275 shares of Elevance Health worth $1.27M as of Q3 2026.
- Grove Bank & Trust bought 207 Elevance Health shares in Q3 2026, an estimated $82.6K.
- Elevance Health made up 0.13% of Grove Bank & Trust's portfolio in Q3 2026, its #103 holding.
- Grove Bank & Trust first reported a position in Elevance Health in Q4 2015 and has held it in 28 quarters since.
- 64 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on Grove Bank & Trust's 13F filing for Q3 2026, filed 8 Oct 2026.